» Articles » PMID: 20484588

Multifocal ERG Defects Associated with Insufficient Long-term Glycemic Control in Adolescents with Type 1 Diabetes

Overview
Specialty Ophthalmology
Date 2010 May 21
PMID 20484588
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the relationship between long-term glycemic control and localized neuroretinal function in adolescents with type 1 diabetes (T1D) without diabetic retinopathy (DR).

Methods: Standard (103 hexagons) and slow-flash (61 hexagons) multifocal ERGs (standard mfERG and sf mfERG) were recorded in 48 patients and 45 control subjects. Hexagons with delayed responses were identified as abnormal. Negative binomial regression analysis was conducted with the number of abnormal hexagons as the outcome variable. Glycated hemoglobin (HbA(1c)) levels, time since diagnosis of T1D, age at diagnosis of T1D, age at testing, and sex were the covariates. Another model replacing HbA(1c) closest to the date of testing with a 1-year average was also generated.

Results: There were more abnormal hexagons for mfOPs in patients than in control subjects (P = 0.005). There was no significant difference in the mean number of abnormal hexagons for standard mfERG responses between patients and control subjects (P = 0.11). Negative binomial regression analysis for the standard mfERG data demonstrated that a 1-unit increase in HbA(1c) was associated with an 80% increase in the number of abnormal hexagons (P = 0.002), when controlling for age at testing. Analysis using the 1-year HbA(1c) averages did not result in significant findings.

Conclusions: Poor long-term glycemic control is associated with an increase in areas of localized neuroretinal dysfunction in adolescents with T1D and no clinically visible DR. Stricter glucose control during the early stages of the disease may prevent neuroretinal dysfunction in this cohort.

Citing Articles

Early detection of retinal dysfunction in type 1 diabetes without retinopathy using multifocal electroretinography.

Arias-Alvarez M, Sopena-Pinilla M, Fernandez-Espinosa G, Orduna-Hospital E, Rodriguez-Mena D, Pinilla I Sci Rep. 2025; 15(1):6379.

PMID: 39984539 PMC: 11845453. DOI: 10.1038/s41598-025-89734-2.


Contrast sensitivity function under three light conditions in patients with type 1 diabetes mellitus without retinopathy: a cross-sectional, case-control study.

Silva-Viguera M, Garcia-Romera M, Bautista-Llamas M Graefes Arch Clin Exp Ophthalmol. 2023; 261(9):2497-2505.

PMID: 37039937 PMC: 10432366. DOI: 10.1007/s00417-023-06057-6.


Serum glial fibrillary acidic protein and neurofilament light chain as biomarkers of retinal neurodysfunction in early diabetic retinopathy: results of the EUROCONDOR study.

Hernandez C, Simo-Servat O, Porta M, Grauslund J, Harding S, Frydkjaer-Olsen U Acta Diabetol. 2023; 60(6):837-844.

PMID: 36959506 DOI: 10.1007/s00592-023-02076-1.


Clinical electroretinography in diabetic retinopathy: a review.

McAnany J, Persidina O, Park J Surv Ophthalmol. 2021; 67(3):712-722.

PMID: 34487740 PMC: 9158180. DOI: 10.1016/j.survophthal.2021.08.011.


Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.

Zafar S, Sachdeva M, Frankfort B, Channa R Curr Diab Rep. 2019; 19(4):17.

PMID: 30806815 PMC: 7192364. DOI: 10.1007/s11892-019-1134-5.


References
1.
Marmor M, Fulton A, Holder G, Miyake Y, Brigell M, Bach M . ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2008; 118(1):69-77. DOI: 10.1007/s10633-008-9155-4. View

2.
Townsend R, Kapoor S . The effect of intensive treatment of diabetes mellitus. N Engl J Med. 1994; 330(9):641; author reply 642. DOI: 10.1056/NEJM199403033300914. View

3.
Cai J, Boulton M . The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye (Lond). 2002; 16(3):242-60. DOI: 10.1038/sj.eye.6700133. View

4.
Shirao Y, Kawasaki K . Electrical responses from diabetic retina. Prog Retin Eye Res. 1998; 17(1):59-76. DOI: 10.1016/s1350-9462(97)00005-0. View

5.
Klein R, Klein B, Moss S, Davis M, DeMets D . The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984; 102(4):520-6. DOI: 10.1001/archopht.1984.01040030398010. View